Primary Insider Notification

15. Jun 2018 | 1 min read

Bård Sundrehagen, Chief Executive Officer in Gentian Diagnostics AS, has today sold 50,000 Shares in Gentian Diagnostics AS at a price of NOK 50 per share. Following the transaction, the total holding held by Bård Sundrehagen is 307,010 shares.

 

MeldingsID: 453767
UtstederID: GENT-ME
Instrument: GENT-ME
Marked: Merkur Market
Kategori: MELDEPLIKTIG HANDEL FOR PRIMÆRINNSIDERE
Informasjonspliktige opplysninger: Ja

Vedlegg: Primary insider notification Baard Sundrehagen (4)

You may also read


Nov 11, 2025 - Ole Sørlie

Financial calendar

Financial calendar for Gentian Diagnostics ASA

Oct 23, 2025 - Ole Sørlie

Study Confirms the Value of Calprotectin in Early Detection of Neonatal Infections and Sepsis

Belgrade, October 23, 2025 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..